| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 06/15/2005 | EP1539677A2 Succinic acid semi-amides as anti-corrosives agents |
| 06/15/2005 | EP1539676A1 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom |
| 06/15/2005 | EP1539662A1 Cannabinoid receptor ligands |
| 06/15/2005 | EP1539134A2 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/15/2005 | EP1278740B1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 06/15/2005 | EP1256576B1 Fused imidazolium derivatives |
| 06/15/2005 | EP1064252B1 Oxidation dyeing compositions containing a cationic coupling agent, novel cationic coupling agents |
| 06/15/2005 | EP0956031B1 Inhibition of 26 s and 20 s proteasome by indanones |
| 06/15/2005 | CN1628109A Novel aryl- and heteroarylpiperazines |
| 06/15/2005 | CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 06/15/2005 | CN1627946A Carboximide derivatives as useful uro-selective alpha-1A adrenoceptor blockers |
| 06/15/2005 | CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones |
| 06/15/2005 | CN1206213C N-arylsulfonyl amino acid omega amides |
| 06/14/2005 | US6906203 Anticancer agents; such as 2-Amino-3-cyano-4-(2-bromo-4,5-dimethoxyphenyl)-4H-indolo(4,5-b)pyran |
| 06/14/2005 | US6906202 Purified racemic lasofoxifene and purified lasofoxifene D-tartrate and a method for effective purification of racemic lasofoxifene |
| 06/14/2005 | US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
| 06/14/2005 | US6906073 Piperazine CCR-3 receptor antagonists |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/14/2005 | CA2155952C Novel process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| 06/09/2005 | WO2005051933A1 An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby |
| 06/09/2005 | WO2005051914A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/09/2005 | WO2005051895A1 Organic compounds |
| 06/09/2005 | WO2005051892A1 Novel phenoxyacetamide derivatives and use thereof for the preparation of diphenylamines |
| 06/09/2005 | WO2005051890A1 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 06/09/2005 | WO2005051373A1 Receptor function regulating agent |
| 06/09/2005 | WO2005040142A9 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 06/09/2005 | WO2004052845A8 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124679 Alpha, beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124632 Use of aminobenzenesulfonic acid derivative or a salt, hydrate, or solvate thereof; treatment of heart failure or arrhythmia in diabetic ischemic heart disease |
| 06/09/2005 | US20050124001 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 06/09/2005 | DE10353910A1 Verfahren zur Synthese optisch aktiver Piperidine Process for the synthesis of optically active piperidines |
| 06/09/2005 | CA2547430A1 Receptor function regulating agent |
| 06/09/2005 | CA2547281A1 Novel phenoxyacetamide derivatives and use thereof for the preparation of diphenylamines |
| 06/09/2005 | CA2546142A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
| 06/08/2005 | EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers |
| 06/08/2005 | EP1537074A1 Cathepsin cysteine protease inhibitors |
| 06/08/2005 | EP1370528B1 Mch antagonists and their use in the treatment of obesity |
| 06/08/2005 | EP1252133B1 Pharmaceutical compounds |
| 06/08/2005 | EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
| 06/08/2005 | EP0849256B1 Amide compounds and use of the same |
| 06/08/2005 | CN1625553A Treatment of male sexual dysfunction |
| 06/08/2005 | CN1625548A Purified LASOFOXIFENE and a method for purification of racemic LASOFOXIFENE by recrystallization |
| 06/08/2005 | CN1623988A Biaryl sulfonamides and methods for using same |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 06/08/2005 | CN1205180C 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 06/08/2005 | CN1205179C (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 06/08/2005 | CN1205177C Process for producing depsipeptide derivs, and noval intermidiates therefor |
| 06/07/2005 | US6903120 Modulators of dopamine neurotransmission |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903114 Carbocyclic alcohols such as 1,6-dinitronaphthalene-2,3-diol, used as catechol-O-methyltransferase inhibitors, for prophylaxis of Parkinson's disease |
| 06/07/2005 | US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/07/2005 | US6903092 Naphthamide neurokinin antagonists for use as medicaments |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/02/2005 | WO2005049604A2 Antithrombotic aromatic ethers |
| 06/02/2005 | WO2005049594A1 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049593A2 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
| 06/02/2005 | WO2005049570A1 Method for synthesising optically active piperidines by the hydrogenation of optically active pyridines |
| 06/02/2005 | WO2005049561A2 Processes for preparing novel methylene blue derivative |
| 06/02/2005 | WO2005049023A1 Glyt1 transporter inhibitors |
| 06/02/2005 | WO2005049009A1 Methods and agents for inhibiting dynamin-dependent endocytosis |
| 06/02/2005 | WO2005048810A2 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
| 06/02/2005 | WO2004063150A3 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
| 06/02/2005 | US20050119502 (Dialkylamino, morpholino, or imidazolyl)-alkoxyphenolic derivatives as drug delivery agents; improved bioavailability for oral administration |
| 06/02/2005 | US20050119315 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators; potassium channel moderators; prevention fibrillation |
| 06/02/2005 | US20050119306 Blocking transcription factor; culture product of transgenic fungi |
| 06/02/2005 | US20050119275 Antiinflammatory agents; autoimmune disease; Alzheimer's disease; anticancer agents; antiarthritic agents; antidiabetic agents; lupus; interinflammatory agents |
| 06/02/2005 | US20050119252 Ligands of melanocortin receptors and compositions and methods related thereto |
| 06/02/2005 | US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2005 | US20050119245 Alpha -, beta -, and gamma -amino acid derivatives, e.g., S)-2-{N'-[4-(4-Fluoro-phenoxy)-phenyl]-N''-cyano-guanidino}-3-phenyl-N-(3-pyrrolidin-1-yl-propyl)-propionamide for the treatment of central nervous system conditions such as muscle spasticity, tinnitus, epilepsy and neuropathic pain. |
| 06/02/2005 | US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 06/02/2005 | CA2556801A1 Methods and agents for inhibiting dynamin-dependent endocytosis |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 06/01/2005 | EP1534283A1 Formulation of liposomal derivatives of phenylalanine |
| 06/01/2005 | EP1440118B1 Blends of waxes and polymer additives |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP1049679B1 Sulphonamide derivatives for treatment of cns disorders |
| 06/01/2005 | EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 06/01/2005 | EP0993441B1 INHIBITORS OF p38 |
| 06/01/2005 | CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 06/01/2005 | CN1622941A Glutaminyl based DPIV inhibitors |
| 06/01/2005 | CN1204135C 1, 3-dioxolanes with antitussive activity |
| 06/01/2005 | CN1204121C 1, 4-substituted cyclic amine derivatives or dihydro indole derivatives and medicines containing same |
| 06/01/2005 | CN1203898C Perfluoroalkyl-containing metal complexes, its preparing method and use in NMR diagnostics |
| 05/31/2005 | US6900350 In aqueous solution; from secondary amine, dihaloalkane and alkali metal sulfite |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900329 MCH antagonists and their use in the treatment of obesity |
| 05/31/2005 | US6900244 Controlling lipid, cholesterol metabolism; anticholesterol agents |
| 05/31/2005 | US6900237 Sulfonamide compounds as protease inhibitors |
| 05/31/2005 | US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 05/31/2005 | US6899830 Method for producing Grignard compounds |
| 05/26/2005 | WO2005047899A2 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 05/26/2005 | WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | WO2005047230A1 Bis-cationic compounds and use thereof |